» Articles » PMID: 36438574

Endothelial Cilia Dysfunction in Pathogenesis of Hereditary Hemorrhagic Telangiectasia

Overview
Specialty Cell Biology
Date 2022 Nov 28
PMID 36438574
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary hemorrhagic telangiectasia (HHT) is associated with defective capillary network, leading to dilated superficial vessels and arteriovenous malformations (AVMs) in which arteries connect directly to the veins. Loss or haploinsufficiency of components of TGF-β signaling, ALK1, ENG, SMAD4, and BMP9, have been implicated in the pathogenesis AVMs. Emerging evidence suggests that the inability of endothelial cells to detect, transduce and respond to blood flow, during early development, is an underpinning of AVM pathogenesis. Therefore, components of endothelial flow detection may be instrumental in potentiating TGF-β signaling in perfused blood vessels. Here, we argue that endothelial cilium, a microtubule-based and flow-sensitive organelle, serves as a signaling hub by coupling early flow detection with potentiation of the canonical TGF-β signaling in nascent endothelial cells. Emerging evidence from animal models suggest a role for primary cilia in mediating vascular development. We reason, on recent observations, that endothelial cilia are crucial for vascular development and that embryonic loss of endothelial cilia will curtail TGF-β signaling, leading to associated defects in arteriovenous development and impaired vascular stability. Loss or dysfunction of endothelial primary cilia may be implicated in the genesis of AVMs due, in part, to inhibition of ALK1/SMAD4 signaling. We speculate that AVMs constitute part of the increasing spectrum of ciliopathy-associated vascular defects.

Citing Articles

Human iPSCs as Model Systems for BMP-Related Rare Diseases.

Sanchez-Duffhues G, Hiepen C Cells. 2023; 12(17).

PMID: 37681932 PMC: 10487005. DOI: 10.3390/cells12172200.

References
1.
Shovlin C . Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010; 24(6):203-19. DOI: 10.1016/j.blre.2010.07.001. View

2.
Berg J, Gallione C, Stenzel T, Johnson D, Allen W, Schwartz C . The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet. 1997; 61(1):60-7. PMC: 1715857. DOI: 10.1086/513903. View

3.
Li Y, Shang Q, Li P, Yang Z, Yang J, Shi J . BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway. J Mol Cell Cardiol. 2020; 147:92-107. DOI: 10.1016/j.yjmcc.2020.07.010. View

4.
Plumitallo S, Ruiz-Llorente L, Langa C, Morini J, Babini G, Cappelletti D . Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) identifies a new Sp1 binding-site. Gene. 2018; 647:85-92. DOI: 10.1016/j.gene.2018.01.007. View

5.
Bystrevskaya V, Lichkun V, Antonov A, Perov N . An ultrastructural study of centriolar complexes in adult and embryonic human aortic endothelial cells. Tissue Cell. 1988; 20(4):493-503. DOI: 10.1016/0040-8166(88)90052-3. View